Streetbeat News

DCGO

DocGo Inc.

https://www.docgo.com

Industry

Medical - Care Facilities

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Open

3.94

Mkt cap

396M

Volume

124K

High

3.98

P/E Ratio

13.40

52-wk high

6.21

Low

3.84

Div yield

N/A

52-wk low

2.75

DocGo, Inc. held its Q3 2024 earnings call, discussing financial performance and company updates.

Portfolio Pulse from

November 09, 2024 | 6:30 pm

DocGo Inc. (DCGO) reported Q3 earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04 per share. This matches their earnings from the same quarter last year.

Portfolio Pulse from

November 08, 2024 | 12:45 am

DocGo's subsidiary, Ambulnz, has renewed its contract with Bayhealth for another three years, expecting to complete over 20,000 trips. This partnership, ongoing since January 2022, focuses on non-emergency patient transportation.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:37 am

DocGo Inc. has appointed Dr. Stephen K. Klasko as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko brings extensive experience in healthcare leadership and innovation. His appointment is expected to support DocGo's growth and transformation in mobile health services.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 11:38 am

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on DocGo (NASDAQ:DCGO) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 2:53 pm

DocGo is expanding its program to improve healthcare access for Medi-Cal enrollees in California. The initiative targets underserved communities in several counties through a partnership with a major national insurance provider.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 11:37 am

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on DocGo (NASDAQ:DCGO) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 2:38 pm

DocGo shares are trading higher after the company reported better-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 3:11 pm

Parker-Hannifin Corporation (NYSE:PH) and several other US-listed companies saw significant stock price increases on Thursday following better-than-expected financial results. The Dow Jones index also gained over 1%.

Portfolio Pulse from Avi Kapoor

August 08, 2024 | 3:09 pm

DocGo (NASDAQ:DCGO) reported Q2 2024 earnings per share (EPS) of $0.06, missing the analyst consensus estimate of $0.07 by 14.29%. However, the company reported sales of $164.950 million, beating the analyst consensus estimate of $162.633 million by 1.42%. This represents a 31.45% increase over sales of $125.487 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:03 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.